Treatment of Superior Vena Cava Syndrome in Malignant Disease with Mediastinal Involvement

Clinical Scenario

This protocol applies to patients presenting with malignant superior vena cava syndrome in the setting of a mediastinal malignancy. Obstruction of the superior vena cava in this context represents an oncological urgency requiring a directed treatment approach.

Clinical Goal

The primary target is a meaningful decrease in superior vena cava syndrome symptoms, restoring adequate venous drainage and relieving the obstructive burden imposed by the underlying mediastinal malignancy.

Treatment Approach — Partial Overview

Management in this setting involves systemic and locoregional oncological interventions directed at the mediastinal disease. The approach combines more than one treatment modality.

Full regimen, sequencing, and individualised details are available in the complete structured protocol ↓

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.1016/j.jvsv.2026.102491

Radiation treatment and chemotherapy frequently decrease symptoms in patients with mediastinal malignancy.

View source ↗